brain

CyberKnife hypofractionated stereotactic radiotherapy as salvage for progressive malignant brain tumors

Thirteen of the 18 tumors (72%) showed a volume decrease. The average volume change was a decrease of 16 +/- 58% (median: 20%) with a follow-up of 180 +/- 121 days (median: 172 days). Toxicity occurred in only one patient, with symptoms improving on steroids.